(Q44276973)

English

Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates

scientific article published in February 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

cystic fibrosis

0 references

Stenotrophomonas maltophilia

1 reference

based on heuristic

inferred from title

Sylvia Valdezate

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

author name string

Rafael Cantón

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Ana Vindel

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Begoña Sánchez Del Saz

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Luis Maíz

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Fernando Baquero

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

publication date

1 February 2003

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Pediatric Pulmonology

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

99-107

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Microbiology of sputum from patients at cystic fibrosis centers in the United States

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Susceptibility of Xanthomonas maltophilia to six quinolones and study of outer membrane proteins in resistant mutants selected in vitro

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Antimicrobial treatment of pulmonary colonization and infection by pseudomonas aeruginosa in cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Emergence of ofloxacin-resistant Citrobacter freundii and Pseudomonas maltophilia after ofloxacin therapy.

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Plasmid location and molecular heterogeneity of the L1 and L2 beta-lactamase genes of Stenotrophomonas maltophilia.

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Persistence and variability of Stenotrophomonas maltophilia in cystic fibrosis patients, Madrid, 1991-1998.

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Selective media for the quantitation of bacteria in cystic fibrosis sputum.

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Genomic diversity of the genus Stenotrophomonas

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Comparative activities of ciprofloxacin, clinafloxacin, gatifloxacin, gemifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against epidemiologically defined Acinetobacter baumannii strains

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Survival of Stenotrophomonas maltophilia following exposure to concentrations of tobramycin used in aerosolized therapy for cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Susceptibilities of 123 Xanthomonas maltophilia strains to clinafloxacin, PD 131628, PD 138312, PD 140248, ciprofloxacin, and ofloxacin

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Comparative in vitro activity of gatifloxacin against Stenotrophomonas maltophilia and Burkholderia species isolates including evaluation of disk diffusion and E test methods.

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study Group

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Clinical implications of stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: a study of 69 patients at 2 university hospitals

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Stenotrophomonas maltophilia in cystic fibrosis: incidence and prevalence

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Susceptibility of 100 strains of Stenotrophomonas maltophilia to three beta-lactams and five beta-lactam-beta-lactamase inhibitor combinations

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Risk factors for emergence of Stenotrophomonas maltophilia in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Typing of 154 clinical isolates of Stenotrophomonas maltophilia by pulsed-field gel electrophoresis and determination of the in vitro susceptibilities of these strains to 28 antibiotics

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Comparative in vitro activity of quinolones against Stenotrophomonas maltophilia

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Comparative activity of new quinolones against 326 clinical isolates of Stenotrophomonas maltophilia

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

In vitro activity of minocycline against respiratory pathogens from patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10216

21 January 2018

Identifiers

10.1002/PPUL.10216

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44276973&oldid=2109082523"